MiR-26a-5p as a Reference to Normalize MicroRNA qRT-PCR Levels in Plasma Exosomes of Pediatric Hematological Malignancies
Authors:
- Carlotta C. DamantiCDCarlotta C. Damanti
- Enrico GaffoEnrico Gaffo
- Federica LovisaFLFederica Lovisa
- Anna GarbinAGAnna Garbin
- Piero Di BattistaPBPiero Di Battista
- Ilaria GallinganiIGIlaria Gallingani
- Anna TosatoATAnna Tosato
- Marta PillonMarta Pillon
- Elisa CarraroECElisa Carraro
- Maurizio MascarinMMMaurizio Mascarin
- Caterina EliaCECaterina Elia
- Alessandra BiffiABAlessandra Biffi
Open Access
Abstract
Plasma exosomal microRNAs (miRNAs) are considered as valid circulating biomarkers for cancer diagnosis and prognosis. Quantitative real-time polymerase chain reaction (qRT-PCR), the most commonly used technique to assess circulating miRNA levels, requires a normalization step involving uniformly expressed endogenous miRNAs. However, there is still no consensus on reference miRNAs for plasma exosomal miRNA abundance normalization. In this study, we identified a panel of miRNAs with stable abundance by analyzing public plasma exosome RNA-seq data and selected miR-486-5p, miR-26a-5p, miR-423-5p and miR191-5p as candidate normalizers. Next, we tested the abundance variation of these miRNAs by qRT-PCR in plasma exosomes of healthy donors and pediatric patients with anaplastic large cell lymphoma, Burkitt lymphoma, Hodgkin lymphoma and mature B-cell acute lymphoblastic leukemia. MiR-486-5p and miR-26a-5p showed the most stable levels, both between healthy controls and patients and among the malignancies analyzed. In light of previous reports on miRNA stability in different exosome isolation methods, our data indicated that miR-26a-5p is a bona fide reference miRNA for qRT-PCR normalization to evaluate miRNA abundance from circulating plasma exosomes in studies of hematological malignancies.Keywords
Funding Information
- Associazione Italiana per la Ricerca sul Cancro (IG 2018 #21385, IG 2017 #20052)
- Fondazione Umberto Veronesi (Post-Doctoral Fellowship 2020)
- Fondazione Cassa di Risparmio di Padova e Rovigo (grant 17/03)
- Ministero dell’Istruzione, dell’Università e della Ricerca (PRIN 2017 #2017PPS2X4_003)
- Camera di Commercio Venezia (PRIN 2017 #2017PPS2X4_003)
- Fondazione Roche (Roche per la Ricerca 2018)
This publication has 40 references indexed in Scilit:
- U6 is unsuitable for normalization of serum miRNA levels in patients with sepsis or liver fibrosisExperimental & Molecular Medicine, 2013
- NCBI GEO: archive for functional genomics data sets—updateNucleic Acids Research, 2012
- The MicroRNA-17-92 Family of MicroRNA Clusters in Development and DiseaseThe Cancer Journal, 2012
- The Majority of MicroRNAs Detectable in Serum and Saliva Is Concentrated in ExosomesPLOS ONE, 2012
- Reproducibility of quantitative RT-PCR array in miRNA expression profiling and comparison with microarray analysisBMC Genomics, 2009
- miR-21 as a key regulator of oncogenic processesBiochemical Society Transactions, 2009
- Impact of the Methotrexate Administration Dose on the Need for Intrathecal Treatment in Children and Adolescents With Anaplastic Large-Cell Lymphoma: Results of a Randomized Trial of the EICNHL GroupJournal of Clinical Oncology, 2009
- Circulating microRNAs as stable blood-based markers for cancer detectionProceedings of the National Academy of Sciences of the United States of America, 2008
- Normalization of microRNA expression levels in quantitative RT-PCR assays: Identification of suitable reference RNA targets in normal and cancerous human solid tissuesRNA, 2008
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001